Private equity firm buys ultrasound supplier.
Knee scans more likely to be negative when ordered by self-referrals.
For drugs used in the preparation of Tc-99m.
This month's roundup of the latest industry products.
Image intensifier market remains surprisingly stable.
Market expected to triple globally by 2018.
Time is running out for Congress to take action.
Current model can be misleading.
Product has multiple clinical benefits.
Whole-body scan shows clues in heart and brain.
A new technology solution might help.
Government busts imaging firm for kickbacks.
Bang for your buck: CT.
Health facilities seek primary care and non-physician practitioners.
New analysis of health insurance exchange rates.
Software may help reduce repeat scans and biopsies.
Rule will reduce CT and MR reimbursements.
Siemens' Symbia Intevo aims to SPECT/CT.
Nuclear medicine aims to optimize dose, too.
50% of equipment needs replacing.
OPPS rules: Short-term boon for nuclear medicine or long-term gloom?
What's driving the comeback?
Income disparity persists in health care, study finds.
Study estimates cost of top 5 infections.
More stringent screening criteria proposed to avoid low-risk thyroid nodules.
More bang for your buck: radiation therapy
More bang for your buck: X-ray tubes
AATS endorses the Task Force's draft recommendation.
Therapeutic ultrasound heats up.
Reeling from reimbursement cuts, the modality may have a new cash cow.
"Medicine isn't the problem, it's the business of medicine."
17% of medical providers will change EMRs this year.
Insurers are required to cover some screenings.
Evidence is emerging for more appropriate use of imaging.
The market prediction for 2021.
Sometimes disaster preparedness is all talk.
"Profitability in Japanese market is so much higher."
Reimbursement process for Lymphoseek to be streamlined.
PETNET will make a new beta-amyloid imaging agent.
Hospital-born infections' tough, high-tech new foes.
